Pluri Inc

XNAS:PLUR  
4.25
-0.10 (-2.30%)
4:46:39 PM EDT: $4.50 +0.25 (+5.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)34.66M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.4 Million
Adjusted EPS-$0.73
See more estimates
10-Day MA$4.41
50-Day MA$4.74
200-Day MA$4.68
See more pivots

Pluri Inc Stock, XNAS:PLUR

MATAM Advanced Technology Park, Building No. 5, Haifa, Haifa 3508409
Israel
Phone: +972.74.710.8600
Number of Employees: 118

Description

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.